Skip to main content
. 2020 Apr 6;192(14):E351–E360. doi: 10.1503/cmaj.191283

Figure 1:

Figure 1:

Cohort assembly for patients in the sodium–glucose cotransporter-2 (SGLT2) inhibitor user group and the comparator dipeptidyl peptidase-4 (DPP4) inhibitor user group. Note: eGFR = estimated glomerular filtration rate. *To ensure 2 mutually exclusive groups. †Patients were inherently different than the general population in terms of medication management. ‡To ensure new outpatient prescriptions. §To ensure generalizability to usual prescribing.